Placebo number: pl1 clinical trials

A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo "GeparDouze"

This study looks at new ways to treat early triple-negative breast cancer. It combines standard chemotherapy with a newer drug, Atezolizumab (or a dummy drug), to see if it can stop the cancer from coming back. It's a large study, comparing different treatment approaches.